Open AccessComparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States
Author(s) -
Sizheng Steven Zhao,
Joerg Ermann,
Chang Xu,
Houchen Lyu,
Sara K. Tedeschi,
Katherine P. Liao,
Kazuki Yoshida,
Robert J. Moots,
Nicola Goodson,
Daniel H. Solomon
Publication year - 2019
Publication title -
rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.957
H-Index - 173
eISSN - 1462-0332
pISSN - 1462-0324
DOI - 10.1093/rheumatology/kez171
Subject(s) - medicine , ankylosing spondylitis , comorbidity , axial spondyloarthritis , cohort , etanercept , adalimumab , medical prescription , physical therapy , retrospective cohort study , medical record , disease , rheumatoid arthritis , sacroiliitis , pharmacology
This study aimed to compare comorbidities and biologic DMARD (bDMARD) use between AS and non-radiographic axial SpA (nr-axSpA) patients, using a large cohort of patients from routine clinical practice in the United States.